Literature DB >> 7018758

Polymorphonuclear neutrophil iodination response as an estimate of defective yeast opsonization.

D M Roberton, N K Dhanjal, R J Levinsky, J F Mowbray, M W Turner.   

Abstract

Polymorphonuclear neutrophil iodide uptake can be used as a measure of yeast opsonization and optimal assay conditions are described for the identification of sera defective in this function. The use of standard normal and defective sera permits correction of inter-assay variations resulting from the use of different cell donors. The iodination assay correlated well (r = 0.74, P less than 0.001) with a direct assay of yeast opsonization when both were used to measure this function in a panel of 72 sera. Differences in results between the two assay systems for some sera may be explained by a requirement for two different surface-associated opsonic molecules in the initiation of neutrophil metabolic activity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7018758      PMCID: PMC1537125     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  Participation of an early component of complement and Hageman factor in C3 destruction by zymosan.

Authors:  I Gigli; S Koethe; K F Austen
Journal:  Clin Immunol Immunopathol       Date:  1975-07

2.  A rapid objective method for measuring the yeast opsonisation activity of serum.

Authors:  R J Levinsky; B A Harvey; S Paleja
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

3.  A new semiquantitative radiometric opsonin assay. Selective measurement of opsonizing capacity of the alternative pathway.

Authors:  M Yamamura; H Valdimarsson
Journal:  Immunology       Date:  1978-04       Impact factor: 7.397

4.  A defect of the alternative pathway of complement.

Authors:  J F Soothill; B A Harvey
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

5.  Familial opsonization defect associated with fatal infantile dermatitis, infections, and histiocytosis.

Authors:  H Scott; E J Moynahan; R A Risdon; B A Harvey; J F Soothill
Journal:  Arch Dis Child       Date:  1975-04       Impact factor: 3.791

6.  Quantitative leukocyte iodination.

Authors:  S H Pincus; S J Klebanoff
Journal:  N Engl J Med       Date:  1971-04-08       Impact factor: 91.245

7.  Iodination by human polymorphonuclear leukocytes: a re-evaluation.

Authors:  S J Klebanoff; R A Clark
Journal:  J Lab Clin Med       Date:  1977-03

8.  Defective opsonization. A common immunity deficiency.

Authors:  J F Soothill; B A Harvey
Journal:  Arch Dis Child       Date:  1976-02       Impact factor: 3.791

9.  Participation of C3 in intracellular killing of Candida albicans.

Authors:  M Yamamura; H Valdimarsson
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

10.  Independent effects of IgG and complement upon human polymorphonuclear leukocyte function.

Authors:  I M Goldstein; H B Kaplan; A Radin; M Frosch
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

View more
  5 in total

1.  The level of mannan-binding protein regulates the binding of complement-derived opsonins to mannan and zymosan at low serum concentrations.

Authors:  M Super; R J Levinsky; M W Turner
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

2.  Suboptimal C3b/C3bi deposition and defective yeast opsonization. I. Evidence for the absence of essential co-factor activity.

Authors:  M W Turner; N D Seymour; M D Kazatchkine; J F Mowbray
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

3.  Evaluation of C3b/C3bi opsonization and chemiluminescence with selected yeasts and bacteria using sera of different opsonic potential.

Authors:  M W Turner; C Grant; N D Seymour; B Harvey; R J Levinsky
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

4.  Murine anti-lymphocyte monoclonal antibodies fail to act as opsonins for allogeneic human peripheral blood polymorphonuclear phagocytes.

Authors:  D M Roberton; G M Georgiou; W M Ellis; C S Hosking
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

5.  A study of C3b deposition on yeast surfaces by sera of known opsonic potential.

Authors:  M W Turner; J F Mowbray; D R Roberton
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.